PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.62%
Revenue growth similar to ADI's 5.97%. Walter Schloss would see if both companies share industry tailwinds.
14.26%
Gross profit growth above 1.5x ADI's 8.18%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
51.57%
EBIT growth above 1.5x ADI's 24.69%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
129.37%
Operating income growth above 1.5x ADI's 24.69%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
82.32%
Net income growth above 1.5x ADI's 25.34%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
84.37%
EPS growth above 1.5x ADI's 23.26%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
81.25%
Diluted EPS growth above 1.5x ADI's 23.81%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.36%
Share reduction while ADI is at 1.30%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.53%
Reduced diluted shares while ADI is at 1.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
33.67%
Dividend growth above 1.5x ADI's 13.66%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
87.22%
OCF growth 1.25-1.5x ADI's 59.64%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
109.06%
FCF growth above 1.5x ADI's 61.78%. David Dodd would verify if the firm’s strategic investments yield superior returns.
104.15%
10Y revenue/share CAGR above 1.5x ADI's 55.63%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
8.82%
Positive 5Y CAGR while ADI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-4.55%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
179.43%
10Y OCF/share CAGR in line with ADI's 178.59%. Walter Schloss would see both as similarly efficient over the decade.
55.41%
5Y OCF/share CAGR is similar to ADI's 55.13%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
31.35%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
754.81%
Net income/share CAGR above 1.5x ADI's 173.29% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
34.33%
5Y net income/share CAGR above 1.5x ADI's 16.73%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-6.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
58.52%
10Y equity/share CAGR at 75-90% of ADI's 72.95%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
32.67%
Below 50% of ADI's 82.87%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
24.26%
Below 50% of ADI's 49.50%. Michael Burry suspects a serious short-term disadvantage in building book value.
1208.79%
Dividend/share CAGR of 1208.79% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
180.15%
5Y dividend/share CAGR above 1.5x ADI's 87.81%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
130.21%
3Y dividend/share CAGR above 1.5x ADI's 69.84%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
11.85%
AR growth well above ADI's 1.32%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.18%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.54%
Negative asset growth while ADI invests at 2.17%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.43%
75-90% of ADI's 1.83%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-9.11%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-7.16%
Our R&D shrinks while ADI invests at 2.35%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.61%
SG&A declining or stable vs. ADI's 5.27%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.